GENE ONLINE|News &
Opinion
Blog

Daiichi Sankyo
Manufacturing Novo NordiskJohnson & JohnsonAmgenBristol Myers SquibbAstraZenecaMerck KGaAModernaDaiichi Sankyo
Pharmaceutical Giants Expand Research and Manufacturing Capabilities, Fueling 2024 Innovation and Growth
2024-03-01
Editors' Picks Healthcare Industrybiotechbiopharma
GeneOnline’s Pick – Top 10 Global Industry News Stories in 2023 (Part 2)
2024-01-15
Editors' Picks weekly highlights
GeneOnline’s Weekly News Highlights: Oct 16-Oct 20
2023-10-24
Partnerships ADCsCancer
Merck Joins Forces with Daiichi Sankyo in $5.5 Billion Deal to Develop Cancer Drugs
2023-10-22
Policy Patent Infringement
Novartis Ordered to Pay $177.8 million to Plexxikon for Patent Infringements
2022-10-03
Special ASCO
ASCO 2022: AstraZeneca, Pfizer, Novartis Share Key Data on Breast Cancer Therapeutics
2022-06-07
Trials & Approvals Breast Cancer
FDA Grants AstraZeneca and Daiichi Sankyo’s Breast Cancer Drug Its Fifth Breakthrough Label
2022-04-28
Asia-Pacific CAR T-cell TherapyB-cell Lymphoma
Daiichi Sankyo Authorizes First Yescarta Treatment Site in Japan
2021-12-17
Asia-Pacific COVID-19
Daiichi Sankyo to Launch mRNA COVID-19 Vaccine in 2022, Shionogi Presents Clinical Results of COVID-19 Oral Drug
2021-10-22
Asia-Pacific Japan
Daiichi Sankyo Partners with Lilly on a Second Migraine Drug Deal in Japan
2021-09-01
COVID-19 Vaccine
Japan Accelerates Vaccine Development, Advances Two More Indigenous Candidates to Trials
2021-03-24
Trials & Approvals Gastric Cancer
AstraZeneca, Daiichi Sankyo’s Potential Blockbuster Bags Second US Approval, This Time for Gastric Cancer
2021-01-22
Deals Gene Therapy
Daiichi Sankyo Collaboration Marks ViGeneron’s Second Gene Therapy Deal in a Single Month
2021-01-19
NDA
Daiichi Sankyo Files NDA for a New Oncolytic Virus in Japan
2021-01-07
Funding
AstraZeneca, Daiichi Sankyo Ink $6 Billion Deal for Lung and Breast Cancer Treatments
2020-07-28
1 2
LATEST
Sanofi and Regeneron’s Dupixent Approved as First-in-World Treatment For Uncontrolled COPD
2024-07-04
Advancements in Alzheimer’s Disease Drug Innovation and Funding Programs in 2024
2024-07-04
FDA Greenlights Eli Lilly’s Groundbreaking Alzheimer’s Drug Kisunla for Early Symptomatic Treatment
2024-07-04
BIO Asia–Taiwan 2024 Set to Showcase Global Biotech Industry Talent on July 24th
2024-07-03
Novo Nordisk’s CLARION-CKD Trial Shut Down After Unsuccessful Results Causing Impairment Loss
2024-07-03
Tanvex BioPharma Secures Asia’s First FDA Approval for Filgrastim Biosimilar, Seizing a $403 Million Market
2024-07-03
Ginkgo Job Cuts Expected to Affect at Least 35% of Workforce, Eliminating Over 400 Jobs
2024-07-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top